Lifecore Biomedical Inc (NAS:LFCR)
$ 7.63 0.22 (2.97%) Market Cap: 280.99 Mil Enterprise Value: 412.33 Mil PE Ratio: 152.60 PB Ratio: 0 GF Score: 65/100

Q4 2019 Landec Corp Earnings Call Transcript

Jul 31, 2019 / 03:00PM GMT
Release Date Price: $11.17 (+3.14%)
Operator

Good day, ladies and gentlemen, and welcome to the fourth quarter and fiscal year-end 2019 earnings conference call. (Operator Instructions) As a reminder, today's program is being recorded. And I will now introduce your host for today's program, Dr. Albert Bolles, President and CEO of Landec Corporation. Please go ahead.

Albert D. Bolles
Landec Corporation - CEO & Director

Good morning and thank you for joining Landec's Fourth Quarter and Fiscal Year 2019 Earnings Call. With me on the call today is Greg Skinner, Landec's Chief Financial Officer. During today's call, we may make forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ materially. These risks are outlined in our filings with the Securities and Exchange Commission, including the Company's Form 10-K for fiscal year 2018.

As a leading innovator in diversified health and wellness solutions, Landec is comprised of two operating business units, Lifecore Biomedical and Curation Foods. Lifecore Biomedical is a fully integrated

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot